Exabis Library
Welcome to the e-CCO Library!
DOP069: Dose optimisation using drug and antibody levels can benefit 50% patients prescribed anti-TNF therapy compared with empiric dose adjustment
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
DOP069: Dose optimization using drug and antibody levels can benefit 50% patients prescribed anti TNF therapy compared to empiric dose adjustment
2016
ECCO'16 DOP
1
DOP069: Improved quality of care quality of life for IBD patients using mobile based remote monitoring platform: A randomised control trial
2018
ECCO'18 Vienna
Tuesday, 8 May 2018, 11:36 AM
1
DOP069: Improved quality of care and quality of life for IBD patients using mobile based remote monitoring platform: A randomised control trial
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
DOP069: Natural history of dysplasia and colorectal cancer in IBD patients in Belgium tertiary care centers
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
DOP069: Natural history of dysplasia and colorectal cancer in IBD patients in Belgium tertiary care centers
2017
ECCO'17 Barcelona
1
DOP06: Antibiotics as a risk factor for older onset IBD: A population-based cohort study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
DOP06: Deep characterization of IL-23 pathway in different gut segments and associated plasma biomarkers in inflammatory bowel disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 2:22 PM
DOP06: Deep characterization of IL-23 pathway in different gut segments and associated plasma biomarkers in inflammatory bowel disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
DOP06: Development of simplified scoring system to predict two-year clinical remission of patients with Ulcerative Colitis after treatment with vedolizumab
2024
ECCO'24 Stockholm
Tuesday, 30 April 2024, 5:03 PM
DOP06: Dynamic shifts in the balance of gut homing Treg and Th17 cells play a critical role in ulcerative colitis and may predict response to vedolizumab therapy
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
DOP06: Histologic activity in Ulcerative Colitis patients achieving endoscopic healing is associated with higher rate of relapse and a distinct mucosal microbial and transcriptional profile
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
DOP06: Non-invasive identification of adherent-invasive E. coli in patients with Crohn's Disease
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 5:40 PM
DOP06: Non-invasive identification of adherent-invasive E. coli in patients with Crohn's Disease
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 4:58 PM
1
DOP07 Long-term results of 4.5 years of faecal microbiota transplantation for treatment of refractory ulcerative colitis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
DOP070: Development and pilot of an index to identify young people with Inflammatory Bowel Disease at risk of psychological morbidity
2018
ECCO'18 Vienna
Tuesday, 8 May 2018, 11:36 AM
1
DOP070: Development and pilot of an index to identify young people with inflammatory bowel disease at risk of psychological morbidity
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
DOP070: Endoscopic response to induction therapy with TNF inhibitors is the best predictor of long term mucosal healing in Crohn's disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
DOP070: Endoscopic response to induction therapy with TNF inhibitors is the best predictor of long term mucosal healing in Crohn’s Disease
2017
ECCO'17 Barcelona
1
DOP070: The relationship between vedolizumab drug concentrations at or before week 6 and remission at week 14 in ulcerative colitis patients from GEMINI 1
2016
ECCO'16 DOP
1